Bristol Myers Squibb reports $12.97 billion revenue for quarter ended June 30, 2026, up 5.7%
Bristol Myers Squibb reported revenue of $12.97 billion for the quarter ended June 30, 2026, an increase of 5.7% from the same quarter a year earlier ($12.27 billion).
For the same period it posted net income of $3.32 billion, up 153.2%, or $1.62 per diluted share (0.64 a year earlier).
That is a net margin of 25.6%.
On Sanad's AAOIFI Standard 21 screen, Bristol Myers Squibb is currently not compliant: interest-bearing debt is 34.8% of market capitalisation (limit 30%), and impure income is 1.2% of revenue (limit 5%).
Is Bristol Myers Squibb halal?
See the full AAOIFI screening of Bristol Myers Squibb
See the full AAOIFI screening of Bristol Myers Squibb
Source: 10-Q filed with the U.S. Securities and Exchange Commission on July 30, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.